| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/31/2004 | EP1121349B1 Substituted thiadiazolsulfonamides used as interleukin-1-beta inhibitors |
| 03/31/2004 | EP1102766B1 Triazolopyridines for the treatment of thrombosis disorders |
| 03/31/2004 | EP1095040B1 New benzoxazoles with pde-inhibiting activity |
| 03/31/2004 | EP1073438B1 8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDYLIDINE)-5H-BENZO (5,6) CYCLOHEPTA (1,2-b) PYRIDINE ORAL COMPOSITIONS |
| 03/31/2004 | EP1051398B1 Thermodynamically stable form of (r)-3- (4-fluorophenyl) sulphonyl]amino] -1,2,3,4- tetrahydro -9h-carbazole -9-propanoic acid (ramatroban) |
| 03/31/2004 | EP1043987A4 Use of serine protease inhibitors to inhibit pathophysiology and neuropathology in a host |
| 03/31/2004 | EP1032581B1 Chemical synthesis of 6-o-alkyl erythromycin a |
| 03/31/2004 | EP1032580B1 Process for n-desmethylating erythromycins and derivatives thereof |
| 03/31/2004 | EP1025098B1 Benzothiophenes |
| 03/31/2004 | EP1021439B1 Crystalline antifungal polymorph |
| 03/31/2004 | EP1015421B1 New phenylamidine derivatives, a process for preparing the same and their use as medicaments |
| 03/31/2004 | EP1011710A4 Methods and compositions for optimization of oxygen transport by cell-free systems |
| 03/31/2004 | EP1010425B1 Remedies for irritable bowel syndrome |
| 03/31/2004 | EP1003720B1 Aryloxyarylsulfonylamino hydroxamic acid derivatives |
| 03/31/2004 | EP0996431B1 Synergistic compositions of lycopene and vitamin e for the prevention of ldl oxidation |
| 03/31/2004 | EP0994705B1 Therapeutic and dietary compositions containing essential fatty acids and bioactive disulphides |
| 03/31/2004 | EP0988028B1 Use of a composition comprising capsaicin or resiniferatoxin for the treatment of Irritable Bowel Syndrome |
| 03/31/2004 | EP0977578B1 Compositions to enhance the cytoprotective effects of polycyclic phenolic compounds through the synergistic interaction with anti-oxidants |
| 03/31/2004 | EP0956015B1 Pharmaceutical composition containing thymine and kynurenine or tryptophan |
| 03/31/2004 | EP0952835B1 Method of treatment of heart disease caused by chlamydia pneumoniae |
| 03/31/2004 | EP0944828B1 Therapeutic agent with quantitative consumption marker and method of monitoring therapeutic agent consumption |
| 03/31/2004 | EP0939625B1 2-cyclopenten-1-one as an inducer of hsp70 |
| 03/31/2004 | EP0937030B1 3-amino-propoxyphenyl derivatives (i) |
| 03/31/2004 | EP0901470B1 Indole derivatives useful as endothelin receptor antagonists |
| 03/31/2004 | EP0877563B1 Food and vitamin preparations containing the natural isomer of reduced folates |
| 03/31/2004 | EP0874852B1 Oxazolidinone antibacterial agent with tricyclic substituents |
| 03/31/2004 | EP0873130B1 Compositions comprising pvp having an average molecular weight in the range of 7.000 to 12.000 daltons |
| 03/31/2004 | EP0871439B1 Substituted (aryl, heteroaryl, arylmethyl or heteroarylmethyl) hydroxamic acid compounds |
| 03/31/2004 | EP0866860B1 Novel tyrosine kinase receptors and ligands |
| 03/31/2004 | EP0858343B1 Continuous low-dose cytokine infusion therapy |
| 03/31/2004 | EP0809498B1 Pharmaceuitical composition for topical application containing acyclovir and hydrocortisone |
| 03/31/2004 | EP0808316B1 Vasoconstrictive substituted 2,3-dihydro-1,4-dioxinopyridines |
| 03/31/2004 | EP0796262B1 7-alkylidene cephalosporanic acid derivatives and methods of using the same |
| 03/31/2004 | EP0793668B1 Derivatives of carbohydrates and compositions containing them |
| 03/31/2004 | EP0788358B1 Use of pyrazole compounds for the treatment of glomerulonephritis, cancer, atherosclerosis or restenosis |
| 03/31/2004 | EP0781766B1 Heterocyclic derivative and medicine |
| 03/31/2004 | EP0777484B1 Intravenous alendronate formulations |
| 03/31/2004 | EP0772445B1 Pharmaceutical compositions, mainly vaginal suppository, containing many different active ingredients |
| 03/31/2004 | EP0770065B1 Tri-substituted phenyl derivates useful as pde iv inhibitors |
| 03/31/2004 | EP0755249B1 Use of maillard reaction inhibitors for the treatment of amyloidosis-based disease |
| 03/31/2004 | EP0744951B1 Process for producing a sterile prednisolone gel |
| 03/31/2004 | EP0681477B1 Genetic modification of neural stem cells |
| 03/31/2004 | CN1486321A Indole derivative and its medicine application |
| 03/31/2004 | CN1486320A Inhibitors of cruzipain and other cysteine proteases |
| 03/31/2004 | CN1486319A Synthesis of temozolomide and analogs |
| 03/31/2004 | CN1486317A 1-methylcarbapenem derivatives |
| 03/31/2004 | CN1486314A Aminotriazolopyridiine derivatives as adenosine receptor ligands |
| 03/31/2004 | CN1486313A Compounds for use in the treatment of skin conditions |
| 03/31/2004 | CN1486312A Pyrazole compounds useful as protein kinase inhibitors |
| 03/31/2004 | CN1486311A Pyrazole compounds useful as protein kinase inhibitors |
| 03/31/2004 | CN1486310A Pyrazole compounds useful as protein kinase inhibitors |
| 03/31/2004 | CN1486309A Tetrahydroazepine derivatives useful as dopamine d3 receptor modulators (antipsychotic agents) |
| 03/31/2004 | CN1486308A Piperazinylcarbonylquinolines and -isoquinolines |
| 03/31/2004 | CN1486302A Abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 03/31/2004 | CN1486301A 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 03/31/2004 | CN1486300A 1,4-disubstituted piperazine derivatives useful as uro-selective dollar g(a)1-adrenoceptor blockers |
| 03/31/2004 | CN1486298A Prodrugs of excitatory amino acids |
| 03/31/2004 | CN1486205A Use of flumazenil in developing a drug for the treatment of alcohol dependence |
| 03/31/2004 | CN1486196A Complex of modafinil and cyclodextrin |
| 03/31/2004 | CN1486195A Methods for reducing chronic stress in mammals |
| 03/31/2004 | CN1486194A Colorstrum-based composition |
| 03/31/2004 | CN1486193A Effective antitumour treatments |
| 03/31/2004 | CN1486191A Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors |
| 03/31/2004 | CN1486187A L-histidine in ophthalmic solutions |
| 03/31/2004 | CN1486186A Improved ophthalmic and contact lens solutions containing forms of vitamin B |
| 03/31/2004 | CN1486185A Stabilized brivudine topical formulations containing metal oxide pigments |
| 03/31/2004 | CN1486184A Lactam compound to inhibit beta-amyloid peptide release or synthesis |
| 03/31/2004 | CN1486183A Treatment of anti-depression drug-induced sexual dysfunction with apomorphine |
| 03/31/2004 | CN1486182A Medicinal compositions |
| 03/31/2004 | CN1486181A Lipid peroxide-lowering compositions |
| 03/31/2004 | CN1486180A Methods for treating neuropsychiatric disorders with NMDA receptor antagonists |
| 03/31/2004 | CN1486179A Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration |
| 03/31/2004 | CN1486177A Method and preparation for binding acetaldehyde in saliva, stomach and large intestine |
| 03/31/2004 | CN1486176A Pharmaceutical compositions comprising amlodipine maleate |
| 03/31/2004 | CN1486175A Powdery preparations and proecss for producing the same |
| 03/31/2004 | CN1486174A Cosmetic method of treating skin |
| 03/31/2004 | CN1485347A Chitosan derivatives, their preparation and medical composition containing the same as active component |
| 03/31/2004 | CN1485327A Tiemomium azoleamine-8-carboxylic acid ester and 8-amide derivatives,its synthesizing method and application in producing anticancer preparation |
| 03/31/2004 | CN1485094A Natural porous polymer beads, the preparation and application thereof |
| 03/31/2004 | CN1485093A Compound acyeterion - metoclopramide preparation |
| 03/31/2004 | CN1485072A Coix seed oil soft capsule for curing prostate diseases and the application thereof |
| 03/31/2004 | CN1485061A Gingko leaf drop pill |
| 03/31/2004 | CN1485044A Preparation of medication and food additive from low molecular weight agar agar |
| 03/31/2004 | CN1485043A Adetphos sodium chloride injection and its preparation method |
| 03/31/2004 | CN1485042A Process of producing bifidobacterium-enriched oral liquid with purgation function |
| 03/31/2004 | CN1485041A Hemin chewing tablet and its preparation method |
| 03/31/2004 | CN1485040A Medication comprising lornoxicam and niacinamide |
| 03/31/2004 | CN1485039A Antalgic, drug addiction-stopping medication and its preparation method |
| 03/31/2004 | CN1485038A Fibrauretine powder and injection preparation |
| 03/31/2004 | CN1485037A Medication comprising nicotinic acid and tatin-like medicine |
| 03/31/2004 | CN1485036A Compound demerol formulation |
| 03/31/2004 | CN1485035A Antiseptic composition of mezlocillin |
| 03/31/2004 | CN1485034A Rifaximin suspension mix granule formulation |
| 03/31/2004 | CN1485033A Rifaximin capsule |
| 03/31/2004 | CN1485032A Use of catechin in preparing medication for preventing and/ or treating pancytopenia |
| 03/31/2004 | CN1485031A Medication oral liquid |
| 03/31/2004 | CN1485030A Compound iron-copper intensified nutrient agent |
| 03/31/2004 | CN1485029A Retinoic acid and the like oral formulation |
| 03/31/2004 | CN1485028A Lycopene drop pill |
| 03/31/2004 | CN1485027A Liposome anti-fungus medication sprayer formulation |